Sustained sympathoinhibitory effects of cardiac resynchronization therapy in severe heart failure

Hypertension

Volumn 44, Issue 5, 2004, Pages 727-731

  Grassi, Guido ^a,b   Vincenti, Antonio ^b   Brambilla, Roberta ^b   Trevano, Fosca Quarti ^a   Dell'Oro, Raffaella ^a,b   Cirò, Antonio ^b   Trocino, Giuseppe ^b   Vincenzi, Antonella ^b   Mancia, Giuseppe ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Autonomic nervous system; Electrical stimulation; Heart failure; Sympathetic nervous system

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADRENERGIC TRANSMISSION; ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; EXERCISE; HEART ATRIUM PACING; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HEART VENTRICLE CONDUCTION; HUMAN; MALE; MUSCLE INNERVATION; PRIORITY JOURNAL; QRS COMPLEX; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIAC PACING, ARTIFICIAL; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; SYMPATHETIC NERVOUS SYSTEM;

EID: 7244239085     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000144271.59333.a7     Document Type: Article

References (34)

1. Saxon LA, Ellenbogen KA. Resynchronization therapy for the treatment of heart failure. Circulation. 2003;108:1044-1048.
2. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108:2596-2603.
3. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289:2685-2694.
4. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, Kopin IJ, Goldstein DS, Esler MD. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676.
5. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Giannattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
6. Cohn JN. Sympathetic nervous system in heart failure. Circulation. 2002;106:2417-2418.
7. Adamson PB, Kleckner KJ, VanHout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability on patients with symptomatic heart failure. Circulation. 2003;108:266-269.
8. Hamdan MH, Zagrodzky JD, Joglar JA, Sheehan CJ, Ramaswamy K, Erdner JF, Page RL, Smith ML. Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction. Circulation. 2000;102:1027-1032.
9. Hamdan MH, Barbera S, Kowal RC, Page RL, Ramaswamy K, Joglar JA, Karimkhani V, Smith ML. Effects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2002;89:1047-1051.
10. Cohn JN, Levine TB, Olivari MT, Garberg B, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
11. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation. 1990;82:1730-1736.
12. Hjemdahl P, Daleskog M, Kahan T. Determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. Life Sci. 1979;25:131-138.
13. Saxon LA, Hourigan L, Guerra P. Influence of programmed AV delay on left ventricular performance in biventricular pacing systems for treatment of heart failure. J Am Coll Cardiol. 2000;35-2A:116A. Abstract.
14. Saxon LA, De Marco T. Resynchronization therapy for heart failure. www.naspe.org/professional_education 2003:24-25.
15. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Pozzi M, Morganti A, Carugo S, Mancia G. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 1997;96:1173-1179.
16. Azevedo ER, Kubo T, Mak S, Al-Hesayen A, Schofield A, Allan R, Kelly S, Newton GE, Floras JS, Parker JD. Nonselective vs selective β-adrenergic receptor blockade in congestive heart failure. Circulation. 2001;104:2194-2199.
17. Esler M, Kaye D. Is very high sympathetic tone in heart failure a result of keeping bad company? Hypertension. 2003;42:870-872.
18. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannnattasio C, Brunani A, Cavagnini F, Mancia G. Sympathetic activation in obese normotensive subjects. Hypertension. 1995;25:560-563.
19. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension. 2000;36:538-542.
20. Grassi G, Seravalle G, Quarti-Trevano F, Dell'Oro R, Bolla G, Mancia G. Effects of hypertension and obesity on sympathetic activation of heart failure patients. Hypertension. 2003;42:873-877.
21. Grassi G, Esler M. How to assess sympathetic activity in humans. J Hypertens. 1999;17:719-734.
22. Esler MD, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitter to the circulation: source, fate and functions. Physiol Rev. 1990;70:963-985.
23. Grassi G, Bolla GB, Seravalle G, Turri C, Lanfranchi A, Mancia G. Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man. Clin Sci. 1997;92:285-289.
24. Shepherd JT. Circulation to skeletal muscle. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: the Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:319-370.
25. Eckberg DL. Sympathovagal balance: a critical appraisal. Circulation. 1997;96:3224-3232.
26. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234-240.
27. Mancia G, Mark AL. Arterial baroreflex in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: the Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:755-793.
28. Mark AL, Mancia G. Cardiopulmonary baroreflex in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology, Section 2: the Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:795-813.
29. Vatner SF, Boettcher DH, Heyndrickx GR, McRitchie RJ. Reduced baroreflex sensitivity with volume loading in conscious dogs. Circ Res. 1975;37:236-242.
30. Thoren P. Characteristics of left ventricular receptors with non-medullated vagal afferents in cats. Circ Res. 1977;40:415-421.
31. Mancia G, Donald DE. Demonstration that atria, ventricles and lungs each are responsible for a tonic inhibition of the vasomotor center in the dog. Circ Res. 1975;36:310-318.
32. Mark AL, Abboud FM, Schmid PG, Heistad DD. Reflex vascular responses to ventricular outflow obstruction and activation of ventricular baroreceptors in dogs. J Clin Invest. 1973;52:1147-1153.
33. Grassi G, Seravalle G, Calhoun DA, Mancia G. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension. 1994;23:294-301.
34. Sinha AM, Skobel EC, Breithard OA, Norra C, Markus KU, Breuer C, Hanrath P, Stellbrink C. Cardiac resynchronization therapy improves central sleep apnea and Cheyne-Stokes in patients with chronic heart failure. J Am Coll Cardiol. 2004;44:68-71.